In this week’s Health Matters newsletter, Ramya Kannan discusses the Nobel Prize in Physiology or Medicine, Indian pharmaceuticals’ deal with U.S. drugmaker Gilead, and anti-cancer drugs soon having QR codes to prevent counterfeits in the market. In this week’s Health Matters newsletter, Ramya Kannan discusses the Nobel Prize in Physiology or Medicine, Indian pharmaceuticals’ deal with U.S. drugmaker Gilead, and anti-cancer drugs soon having QR codes to prevent counterfeits in the market. Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu
The mostly good-news newsletter
